ClinicalTrials.Veeva

Menu

Intervascular Post-Market Clinical Follow-Up (PMCF) Registry

I

Intervascular

Status

Enrolling

Conditions

Aortic Diseases
Peripheral Arterial Diseases
Carotid Artery Diseases

Treatments

Device: Intergard Synergy - Antimicrobial Collagen Coated Vascular Grafts
Device: Intergard Silver - Antimicrobial Collagen Coated Vascular Grafts and Patches
Device: Hemashield - Collagen Coated Vascular Grafts and Patches
Device: Intergard Standard - Collagen Coated Vascular Grafts and Patches

Study type

Observational

Funder types

Industry

Identifiers

NCT07322913
VV-TMF-00090

Details and patient eligibility

About

The purpose of this registry is to evaluate the long-term safety and performance of Intervascular Vascular Grafts and Patches (Intergard Standard, Hemashield, Intergard Silver, Intergard Synergy) for bypass, repair or replacement of aortic, peripheral, or carotid arteries. This registry is intended to further define the expected product lifetime of the devices and to collect data related to usefulness of the antimicrobial coatings.

Enrollment

1,200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Willing, and able to provide legally-effective written informed consent (as required by Institutional Review Board or Ethics Committee)
  • Male and female patients that have undergone bypass, replacement or repair of the peripheral arteries, aorta, or carotid artery using the Intervascular Vascular Grafts and Patches (Intergard Standard, Hemashield, Intergard Silver, Intergard Synergy)
  • Were at least 18 years of age at the time of the procedure
  • Available records for data collection with a minimum of 3 years (36 months) of data/follow-up.

Exclusion criteria

  • Active infection in the region of device placement at the time of implantation of the Intergard Standard and Hemashield Vascular Graft or Patch.

Trial design

1,200 participants in 3 patient groups

Peripheral Arterial Disease (PAD) Cohort
Treatment:
Device: Intergard Standard - Collagen Coated Vascular Grafts and Patches
Device: Hemashield - Collagen Coated Vascular Grafts and Patches
Device: Intergard Silver - Antimicrobial Collagen Coated Vascular Grafts and Patches
Device: Intergard Synergy - Antimicrobial Collagen Coated Vascular Grafts
Aortic Disease Cohort
Treatment:
Device: Intergard Standard - Collagen Coated Vascular Grafts and Patches
Device: Hemashield - Collagen Coated Vascular Grafts and Patches
Device: Intergard Silver - Antimicrobial Collagen Coated Vascular Grafts and Patches
Device: Intergard Synergy - Antimicrobial Collagen Coated Vascular Grafts
Carotid Artery Disease Cohort
Treatment:
Device: Intergard Standard - Collagen Coated Vascular Grafts and Patches
Device: Hemashield - Collagen Coated Vascular Grafts and Patches

Trial contacts and locations

2

Loading...

Central trial contact

Senior Manager, Clinical Affairs

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems